Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS Teva Pharmaceutical Industries, 10 Oct 2012 Accessed on 16 Oct 2012 from http://www.tevapharm.com/Media/News/Pages/2012/1743500.aspx. CommentRecommendBookmarkWatch